Study links inflammatory bowel disease to prostate cancer

Inflammatory bowel disease increases the risk of prostate cancer by four-to-five times, according to a study.

The findings appear in the journal European Urology.

The 20-year study from Northwestern Medicine is the first report to show men with inflammatory bowel disease have higher than average PSA (prostate-specific antigen) values, and this group also has a significantly higher risk of potentially dangerous prostate cancer.